Imatinib-induced interstitial pneumonitis – a literature review and case report
Imatinib is generally well tolerated, with mild common side effects such as nausea and vomiting, diarrhea, muscle cramps, fatigue, skin rash and edema; however, pulmonary complications are uncommon. A 73-year-old woman undergoing one month treatment with Imatinib for chronic myeloid neoplasm associa...
Main Authors: | Olga Hilda Orasan, Andreea Maria Stefan, Iulia Minciuna, Adela Sitar-Taut, George Ciulei, Simina Tarmure, Ioana Para, Flaviu Muresan, Ovidiu Fabian, Sorina Cezara Coste, Vasile Negrean, Angela Cozma, Laura Urian |
---|---|
Format: | Article |
Language: | English |
Published: |
Ion Motofei, Carol Davila University
2020-04-01
|
Series: | Journal of Mind and Medical Sciences |
Subjects: | |
Online Access: | https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1227&context=jmms |
Similar Items
-
A rare complication of imatinib mesylate therapy: drug-induced pneumonitis
by: Ol'ga Veniaminovna Stakhina, et al.
Published: (2010-02-01) -
Imatinib-Induced Interstitial Pneumonitis Successfully Switched to Nilotinib in a Patient with Prior History of Mycobacterium tuberculosis Infection
by: Zhuan - Bo Luo, et al.
Published: (2017-11-01) -
Treatment dilemmas in patients with gastrointestinal stromal tumors (GIST) who experienced imatinib-induced pneumonitis: A case series
by: Deborah van de Wal, et al.
Published: (2024-03-01) -
Interstitial Pneumonitis in a Patient with Chronic Myeloid Leukemia
by: Ahmet Emre Eşkazan, et al.
Published: (2013-12-01) -
Influence of pesticides on respiratory pathology – a literature review
by: Simina Tarmure, et al.
Published: (2020-06-01)